Quickstart Highlights
DSIP dosage protocols can help promote deep, restorative delta-wave sleep and support healthy stress response. Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring nonapeptide (9 amino acids) first isolated from rabbit brain for its ability to enhance slow-wave sleep. Research indicates DSIP may improve sleep quality, normalize sleep architecture, reduce stress-related cortisol patterns, and support mood stabilization without next-day grogginess. This educational protocol presents a once-daily subcutaneous evening approach with nominal volume calculations that require verification against the actual device.
- Reconstitute: Add 1.0 mL BAC water per labelled 10 mg vial; calculations assume a final volume of 1.0 mL and nominal concentration of 10 mg/mL.
- Typical daily range: 100–300 mcg once nightly (gradual titration) for a 2–4 week cycle.
- Scale conversion: At 10 mg/mL, 1 U-100 unit = 0.01 mL = 100 mcg. Confirm actual device markings; this arithmetic does not establish measurement accuracy.
- Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.
Dosing & Reconstitution Guide
Standard / Gradual Approach (1 mL = 10 mg/mL)
| Week | Nightly Dose (mcg) | Calculated volume | U-100 scale value (1 mL capacity) | V1 nominal setting (units) |
|---|---|---|---|---|
| Week 1 | 100 mcg | 0.01 mL | 1 unit | 1 unit |
| Week 2 | 150 mcg | 0.015 mL | 1.5 units (requires matching fractional-unit markings) | Not representable in whole units |
| Week 3 | 200 mcg | 0.02 mL | 2 units | 2 units |
| Week 4 | 250–300 mcg | 0.025–0.03 mL | 2.5–3 units (verify markings) | Endpoints: Not representable in whole units / 3 units; intermediate amounts require a separate check |
Calculation basis: The table uses the labelled 10 mg amount and assumes a final solution volume of 1.0 mL (10 mg/mL). BAC volume does not change the amount of peptide. These are nominal calculations, not validation of preparation, compatibility or treatment.
Frequency: Inject once nightly subcutaneously, approximately 30–60 minutes before bedtime, for 2–4 weeks, then take 2–4 weeks off. Tolerance to the sleep effect builds with continuous use, so short cycles are the norm. For ≤10-unit (≤0.10 mL) administrations, consider 30- or 50-unit insulin syringes for improved readability.
Reconstitution Steps
- Draw 1.0 mL bacteriostatic water with a sterile syringe.
- Inject slowly down the vial wall; avoid foaming.
- Gently swirl/roll until dissolved (do not shake).
- Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
Supplies Needed
Plan based on a 2–4 week nightly cycle with gradual titration.
- Peptide Vials (DSIP, 10 mg each): One vial covers a cycle (about 6 mg used over 4 weeks).
- 2 weeks: 1 vial
- 4 weeks: 1 vial
- Insulin Syringes (U-100):
- Per week: 7 syringes (1/night)
- 2 weeks: 14 syringes
- 4 weeks: 28 syringes
- Bacteriostatic Water (30 mL bottles): Use 1.0 mL per vial → 1 × 30 mL bottle.
- Alcohol Swabs: One for the vial stopper + one for the injection site each injection.
- Per week: 14 swabs
- 2 weeks: 28 swabs
- 4 weeks: 56 swabs → 1 × 100-count box
Protocol Overview
Concise summary of the once-daily evening regimen.
- Goal: Support improved sleep quality, enhanced delta-wave (slow-wave) sleep, and stress modulation over time.
- Schedule: Nightly subcutaneous injections, 30–60 minutes before bed, for 2–4 weeks, followed by 2–4 weeks off.
- Dose Range: 100–300 mcg daily with gradual titration.
- Reconstitution: 1.0 mL BAC per labelled 10 mg vial; nominal 10 mg/mL under the stated final-volume assumption.
- Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw.
Dosing Protocol
Suggested nightly titration approach.
- Start: 100 mcg nightly; increase by ~50 mcg each week as tolerated.
- Target: 250–300 mcg nightly by Week 4.
- Frequency: Once per day (subcutaneous), 30–60 minutes before bedtime.
- Cycle Length: 2–4 weeks on, then 2–4 weeks off. Tolerance to the sleep effect builds with continuous use; short cycles are the norm.
- Timing: Evening dosing to align with natural sleep onset; rotate injection sites.
Storage Instructions
Proper storage preserves peptide quality.
- Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; minimize moisture exposure.
- Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); prepare aliquots if needed and avoid freeze–thaw.
- Allow vials to reach room temperature before opening to reduce condensation uptake.
Important Notes
- Practical considerations for consistency and safety.
- Use new sterile insulin syringes; dispose in a sharps container.
- Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation.
- Inject slowly; wait a few seconds before withdrawing the needle.
- Document daily dose and site rotation to maintain consistency.
- Avoid other sedatives during DSIP use to clearly evaluate its effects on sleep.
How This Works
DSIP acts as a neuromodulator of the sleep-wake cycle and stress response. Administration consistently increases delta-wave (slow-wave) sleep in EEG recordings, suggesting it promotes the initiation and maintenance of deep, non-REM sleep. DSIP readily crosses the blood-brain barrier to exert central effects and may enhance inhibitory neuronal activity or modulate sleep-regulating brain regions. Additionally, DSIP attenuates ACTH and corticosterone release in response to stress, indicating an effect on the hypothalamic-pituitary-adrenal axis. Unlike conventional sedatives, DSIP tends to normalize sleep architecture without next-day grogginess.
Potential Benefits & Side Effects
bservations from preclinical and clinical literature.
- Supports improved sleep quality and increased slow-wave (delta) sleep duration.
- May help normalize disrupted sleep patterns in chronic insomnia.
- Shows potential for stress reduction and mood support through HPA axis modulation.
- Remarkably safe profile: animal studies found no lethal dose even at extremely high doses; human studies report only mild, transient side effects (occasional headache or nausea).
- Occasional mild injection-site reactions (redness/itch) may occur with subcutaneous administration.
Lifestyle Factors
- Complementary strategies for best outcomes.
- Maintain consistent sleep-wake schedules to reinforce circadian rhythm.
- Limit caffeine and screen exposure in the evening hours.
- Create a dark, cool sleep environment to support natural melatonin production.
- Prioritize stress management techniques and regular physical activity during daytime hours.
Injection Technique
General subcutaneous guidance from clinical best-practice resources.
- Clean the vial stopper and skin with alcohol; allow to dry.
- Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue.
- Do not aspirate for subcutaneous injections; inject slowly and steadily.
- Rotate sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy.
- The listed volumes are small. Verify device markings and measurement feasibility; do not round to a different amount.
Recommended Source
Why Amino Labs?
- Third-party tested: Each batch includes Certificate of Analysis (COA) verifying purity and composition.
- Consistent quality: ISO-aligned manufacturing and handling standards ensure reliable product integrity.
- Cold-chain integrity: Temperature-controlled shipping and storage throughout fulfillment process.
- Research-grade purity: Suitable for educational and research applications requiring high-quality peptides.
Note: Product availability and specifications subject to change. Verify current product details on supplier website.
Shop at Amino Labs
Important Note
This content is intended for therapeutic educational purposes only and does not constitute medical advice, diagnosis, or treatment.